Drawing for SLEEP ULTRAPOWER

USPTO serial 77519599

SLEEP ULTRAPOWER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
THOMPSON, HEATHER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SLEEP ULTRAPOWER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer L. Whitelaw

JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N FL 3NAPLES, FL 34103-3590UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Botanical extracts for use in the manufacture of nutraceuticals; extracts for use in the manufacture of pharmaceutical preparations in the form of preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanical extracts for use in the manufacture of pharmaceuticals; chemical extracts extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts, namely, chemical agents made from botanical extracts or association of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanical extracts used in the manufacture of preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanicals and botanical blends, herbs and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; herbal extracts and blends for use in manufacturing functional foods or beverages; herbal extracts and blends for use in manufacturing medicinal foods or beverages; botanical extracts and blends for use in manufacturing functional foods or beverages; botanical extracts and blends for use in manufacturing medicinal foods or beverages; herbal preparations and extracts for use as ingredients in manufacturing in the food, nutrition, nutraceutical and/or pharmaceutical industriesACTIVE—
003Herbal products, namely, aromatherapy packs filled with herbs for use in aromatherapy; pre-moistened non-medicated personal hygiene wipes, namely, herpes relief wipes; herbal and botanical extracts for cosmetic use; algal extracts or algal extract blends for cosmetic use; essential oils; fragrances; fragrances for personal use; food flavorings prepared from essential oilsACTIVE—
005Nutritional supplements; herbal products, namely, medicated skin and lip balms; herbal products, namely, ointments, oils, drinks, infusions, syrups, herbal extracts, poisons, and tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products, namely, ointments, oils, namely, mineral oil for use as a laxative; drinks, namely, meal replacement drinks, dietary supplement drinks, medicinal drinks, and fish oil for use as a dietary supplement or in a nutraceutical; infusions and syrups, namely, cough syrups; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, herbal extracts and syrups; medicinal herb extracts; medicinal herb extracts for medical purposes; plant extracts for medical, pharmaceutical, nutraceutical and nutritional purposes; medicinal extracts used in preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; medicinal extracts in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; medicinal herbal extracts in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; medicinal botanical extracts in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; yeast extracts for medical, pharmaceutical or nutraceutical purposes; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; herbal products, namely, herbal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for diabetics, infants and enteral feeding; botanical extracts for nutritional use; botanical extracts for medical, veterinary, nutraceutical and pharmaceutical purposes; designer extracts, namely, herbal extracts for medical, veterinary and pharmaceutical purposes; botanical extracts for nutritional supplements, nutraceuticals and pharmaceuticals; nutritional dietary supplements; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; nutraceuticals, namely, vitamins and food supplements; food for medically restricted diets; supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; food supplements, namely, anti-oxidants; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as components of nutritional supplements and vitamins; nutritional oils not for cosmetic purposes; food supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; anti-cough drops; cough drops; cough expectorants; throat lozenges; cough lozenges; cough syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention herpes; biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type II or Herpes Zoster virus, not in intravenous form; plant-based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", Herpes Simplex virus 1, Herpes Simplex virus 2, Varicella Zoster virus "herpes zoster" or "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immunedeficiency virus "HIV", roseola infantum, human herpes IV; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes, herpes zoster and AIDS; algal products for medicinal purposes, namely, algal extracts or algal extract blends for use as nutritional and dietary supplements; algal products, namely, algal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; algal products, namely, algal powders for nutritional purposes; algal extracts or algal extract blends for medical or pharmaceutical purposes; functional foods, namely, dietetic foods adapted for medical purposes; functional beverages, namely, nutritionally fortified beverages; medicinal foods, namely, processed food for medical purposes; animal health products, namely, animal feed supplements, medicated animal feed, micro-nutrient animal feed, dietary supplements for animals, non-medicated additives for animal feed for use as nutritional supplements, nutritional drinks for animals, pharmaceutical preparations for animal skincare; plant extracts for medical, veterinary and pharmaceutical purposes; herbal extracts for medical, veterinary and pharmaceutical purposes; designer extracts, namely, plant, herbal and botanical extracts for medical, veterinary and pharmaceutical purposes; and biodefense products, namely, medicinal preparations for the treatment of infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; mushroom, fungus, or spore extracts or blends as supplements, nutrition, nutraceuticals and/or pharmaceuticals; botanical extracts for nutritional use; nutritionally fortified beverages; nutritionally fortified beverages for immune enhancement, and nutritionally fortified beverages with rice bran and wheat bran; medicinal beverages; soy protein for use as a nutritional supplement; nutritional additives for medical or nonmedical purposes for use in manufacturing foods and dietary supplements for human consumption; active principles extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals; active principles extracted from medicinal plants for use in the manufacture of pharmaceutical or nutraceutical productsACTIVE—
029Beverages, namely, yogurt-based beverages; food beverages, namely, dairy-based food beverages, fruit-based food beverages, vegetable-based food beverages, dairy-based chocolate food beverages, soy-based food beverage used as a milk substitute, vegetable-based chocolate food beverages and peanut-based food beverages; milk beverages; milk beverages, namely, milk, milk beverages containing fruits, milk beverages with high milk content, milk based beverages containing fruit juice and milk beverages containing coffee; milk powder; milk powder for nutritional purposes; powdered milk for food purposes; functional foods, namely, dairy-based food beverages, fruit-based food beverages, vegetable-based food beverages, dairy-based chocolate food beverages, soy-based food beverage used as a milk substitute, vegetable-based chocolate food beverages, nut-based food beverages, milk, milk beverages containing fruits, milk beverages with high milk content, milk based beverages containing fruit juice, and milk beverages containing coffee; edible oils, namely, omega oil extracts and fish oil extracts; soy protein for use as a food additive; mushroom, fungus, or spore extracts or blends thereof for use as food additivesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 29, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 29, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 25, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 2, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2009NPUBNOTICE OF PUBLICATION—
Mar 23, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 11, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 10, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 9, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2009ALIEASSIGNED TO LIE—
Mar 3, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2008GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Sep 4, 2008GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Sep 4, 2008CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Aug 20, 2008DOCKASSIGNED TO EXAMINER—
Jul 15, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
Jul 14, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance